Literature DB >> 21192971

The 'resting-state hypothesis' of major depressive disorder-a translational subcortical-cortical framework for a system disorder.

Georg Northoff1, Christine Wiebking, Todd Feinberg, Jaak Panksepp.   

Abstract

Major depressive disorder (MDD) has traditionally been characterized by various psychological symptoms, involvement of diverse functional systems (e.g., somatic, affect, cognition, reward, etc.), and with progress in neuroscience, an increasing number of brain regions. This has led to the general assumption that MDD is a stress-responsive brain 'system disorder' where either one or several alterations infiltrate a large number of functional systems in the brain that control the organism's somatic, affective, and cognitive life. However, while the effects or consequences of the abnormal changes in the functional systems of, for instance affect, cognition or reward have been investigated extensively, the underlying core mechanism(s) underlying MDD remain unknown. Hypotheses are proliferating rapidly, though. Based on recent findings, we will entertain an abnormality in the resting-state activity in MDD to be a core feature. Based on both animal and human data, we hypothesize that abnormal resting-state activity levels may impact stimulus-induced neural activity in medially situated core systems for self-representation as well as external stimulus (especially stress, specifically separation distress) interactions. Moreover, due to nested hierarchy between subcortical and cortical regions, we assume 'highjacking' of higher cortical affective and cognitive functions by lower subcortical primary-process emotional systems. This may account for the predominance of negative affect in somatic and cognitive functional system operations with the consecutive generation of the diverse symptoms in MDD. We will here focus on the neuroanatomical and biochemical basis of resting-state abnormalities in MDD including their linkage to the diverse psychopathological symptoms in depression. However, our 'resting-state hypothesis' may go well beyond that by being sufficiently precise to be linked to genetic, social, immunological, and endocrine dimensions and hypotheses as well as to clinical dimensions like endophenotypes and various diagnostic-prognostic biomarkers. Taken together, our 'resting-state hypothesis' may be considered a first tentative framework for MDD that integrates translational data, the various dimensions, and subcortical-cortical systems while at the same time providing the link to the clinical level of symptoms, endophenotypes and biomarkers.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21192971     DOI: 10.1016/j.neubiorev.2010.12.007

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  65 in total

Review 1.  Interoceptive dysfunction: toward an integrated framework for understanding somatic and affective disturbance in depression.

Authors:  Christopher Harshaw
Journal:  Psychol Bull       Date:  2014-11-03       Impact factor: 17.737

Review 2.  The default mode network and recurrent depression: a neurobiological model of cognitive risk factors.

Authors:  Igor Marchetti; Ernst H W Koster; Edmund J Sonuga-Barke; Rudi De Raedt
Journal:  Neuropsychol Rev       Date:  2012-05-09       Impact factor: 7.444

3.  Distracted and down: neural mechanisms of affective interference in subclinical depression.

Authors:  Roselinde H Kaiser; Jessica R Andrews-Hanna; Jeffrey M Spielberg; Stacie L Warren; Bradley P Sutton; Gregory A Miller; Wendy Heller; Marie T Banich
Journal:  Soc Cogn Affect Neurosci       Date:  2014-07-25       Impact factor: 3.436

4.  Synaptic modifications in the medial prefrontal cortex in susceptibility and resilience to stress.

Authors:  Minghui Wang; Zinaida Perova; Benjamin R Arenkiel; Bo Li
Journal:  J Neurosci       Date:  2014-05-28       Impact factor: 6.167

5.  Enhanced default mode network connectivity with ventral striatum in subthreshold depression individuals.

Authors:  J W Hwang; S C Xin; Y M Ou; W Y Zhang; Y L Liang; J Chen; X Q Yang; X Y Chen; T W Guo; X J Yang; W H Ma; J Li; B C Zhao; Y Tu; J Kong
Journal:  J Psychiatr Res       Date:  2016-02-13       Impact factor: 4.791

6.  Chronic Fluoxetine Induces Activity Changes in Recovery From Poststroke Anxiety, Depression, and Cognitive Impairment.

Authors:  Faranak Vahid-Ansari; Paul R Albert
Journal:  Neurotherapeutics       Date:  2018-01       Impact factor: 7.620

7.  All roads lead to the default-mode network-global source of DMN abnormalities in major depressive disorder.

Authors:  Andrea Scalabrini; Benedetta Vai; Sara Poletti; Stefano Damiani; Clara Mucci; Cristina Colombo; Raffaella Zanardi; Francesco Benedetti; Georg Northoff
Journal:  Neuropsychopharmacology       Date:  2020-08-02       Impact factor: 7.853

8.  Altered Global Signal Topography and Its Different Regional Localization in Motor Cortex and Hippocampus in Mania and Depression.

Authors:  Jianfeng Zhang; Paola Magioncalda; Zirui Huang; Zhonglin Tan; Xiwen Hu; Zhiguo Hu; Benedetta Conio; Mario Amore; Matilde Inglese; Matteo Martino; Georg Northoff
Journal:  Schizophr Bull       Date:  2019-06-18       Impact factor: 9.306

9.  Negative childhood experiences alter a prefrontal-insular-motor cortical network in healthy adults: A preliminary multimodal rsfMRI-fMRI-MRS-dMRI study.

Authors:  Niall W Duncan; Dave J Hayes; Christine Wiebking; Brice Tiret; Karin Pietruska; David Q Chen; Pierre Rainville; Małgorzata Marjańska; Omar Ayad; Julien Doyon; Mojgan Hodaie; Georg Northoff
Journal:  Hum Brain Mapp       Date:  2015-08-19       Impact factor: 5.038

10.  Central serotonin transporter availability in highly obese individuals compared with non-obese controls: A [(11)C] DASB positron emission tomography study.

Authors:  Swen Hesse; Michael Rullmann; Julia Luthardt; Karsten Winter; Mohammed K Hankir; Georg-Alexander Becker; Franziska Zientek; Georg Reissig; Ralf Regenthal; Mandy Drabe; Christian Schinke; Anke Bresch; Katrin Arelin; Donald Lobsien; Marianne Patt; Philipp M Meyer; Mathias Fasshauer; Wiebke K Fenske; Matthias Blüher; Michael Stumvoll; Osama Sabri
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-11-18       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.